An observational study in Total Knee Replacement, sponsored by Xi'an Honghui Hospital. Status unknown at 2 sites in China. Open to female participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-06-29.
Sponsored by Xi'an Honghui Hospital · Observational
Purpose: This study outlines the benefits of the proximal tibia angle (PTA) in evaluation of the pre-operative individual condylar twist angle (CTA) in total knee arthroplasty.
Methods: Condylar twist angle and proximal tibia angle were obtained from 33 female healthy participants using computed tomography (CT). The CTA, angle between clinical transepicondylar axis and posterior condylar line were measured. The PTA is the angle formed between the mechanical axis of the tibia and tibia plateau line. The correlation between the CTA and the PTA was analyzed statistically with the linear regression.
Xi'an Honghui Hospital is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Chinese female patients with primary varus knee OA, scheduled for primary TKAs
Exclusion Criteria:
Measured with computed tomography
Measured with plain Radiography
proximal tibia angle (PTA)
The PTA is the angle formed between the mechanical axis of the tibia and tibia plateau line.
Time frame: Four months
Condylar twist angle (CTA)
The CTA is the angle between clinical transepicondylar axis and posterior condylar line
Time frame: Four months
This study is status unknown, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.